HB Wealth Management LLC Cuts Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

HB Wealth Management LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 7.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,753 shares of the financial services provider’s stock after selling 139 shares during the period. HB Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $241,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Future Financial Wealth Managment LLC purchased a new position in iShares Biotechnology ETF in the first quarter worth about $27,000. Pacifica Partners Inc. boosted its position in shares of iShares Biotechnology ETF by 118.2% during the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after buying an additional 130 shares during the period. Crewe Advisors LLC boosted its position in shares of iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after buying an additional 78 shares during the period. YHB Investment Advisors Inc. purchased a new position in shares of iShares Biotechnology ETF during the first quarter valued at approximately $37,000. Finally, Northwest Financial Advisors purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $42,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $136.20 on Friday. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16. The business has a 50 day simple moving average of $135.33 and a two-hundred day simple moving average of $135.01.

iShares Biotechnology ETF Company Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.